Government policies and regulations have created an environment hostile to research and innovation.
patented drugs
Juillet 29, 2021
12:02PM
Advanced clinical trials in Canada, which were consistent between 2015 and 2019, decreased by 26 per cent in 2020.
Décembre 2, 2020
10:22AM
Drug manufacturers may forgo sales in Canada to increase average reference prices.
Août 14, 2019
7:40PM
Forcing manufacturers of high-cost drugs to reduce their prices by up to 80 per cent is unsustainable.
Septembre 17, 2018
10:43AM
Profit incentivizes innovation and helps fund research and development.
Janvier 19, 2018
1:56PM
Pharmaceutical manufacturers take on a significant investment risk to develop new drugs.
Octobre 18, 2016
2:36PM
The opposition of the two U.S. presidential candidates to the Trans-Pacific Partnership (TPP) threatens progress on trade issues including intellectual property protection.